Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Understand the scenarios where a cash back credit card is the best choice. Make your spending count with this guide.
26,647 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
The AI memory boom has traders watching the Roundhill Memory ETF. With a potential SK Hynix ADR list around July 10, ...
Palantir’s latest quarter reported strong numbers and rising defense-related AI demand, boosting the stock and signal...
Lawmakers unveil the Senior Citizens' Freedom to Work Act, which would end the retirement earnings test and let retir...
A growing trend centers on the HSA receipt trick: medical bills, a tax-free growth strategy that lets you reimburse p...
Tuesday brought a modest pullback for Salesforce as tech stocks wobbled. This article explains the drivers behind the...
A revised look at 2026 shows silver facing both potential gains and headwinds. This article weighs the catalysts for ...
TeraWulf stunned investors with a powerful April rally, rising about 50% as crypto momentum and cost discipline colli...
A common retirement pitfall hinges on COBRA coverage not extending Medicare enrollment windows. This piece explains h...
Progressive Insurance fell today as markets weighed mixed quarterly results. This article breaks down the numbers, ex...
A major bet from a savvy institutional investor puts Brookdale Senior Living in the spotlight. Mason Capital Manageme...